Floatz logo

Zoledronate

Parkinsonism

California Pacific Medical Center Research InstituteSmall moleculePhase 4 / ApprovedDormant
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Parkinsonism cohort.

Asset / SponsorPhaseRating
IOFLUPANE
Mayo Clinic
Phase 4BB
Meta-Iodobenzylguanidine
Mayo Clinic
Phase 4BB
Droxidopa
The Cooper Health System
Phase 4B
Varenicline Tartrate
Corporal Michael J. Crescenz VA Medical Center
Phase 4B
Zonisamide
The Cooper Health System
Phase 4B
ub-312
United Neuroscience Ltd.
Phase 1CC
Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells
Indonesia University
N/AD
Ramelteon
Northwestern University
N/AD

Same molecule, other indications

Zoledronate is also rated in:

metastatic carcinoma in the boneDormant
BBB
Indicative ·
79 / 100
View asset →
osteoporosisDormant
BBB
Indicative ·
76 / 100
View asset →
breast carcinomaDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →